No recent analyst price targets found for DOCMF.
Latest News for DOCMF
Dr. Martens plc (DRMTY) Q3 2026 Sales/Trading Call Transcript
Dr. Martens plc (DRMTY) Q3 2026 Sales/Trading Call Transcript
Dr. Martens Revenue Drops on Europe, Middle East and Africa Weakness
Chief Executive Ije Nwokorie said the EMEA market continued to be challenging, and that the company had taken a more disciplined promotional stance there.
Dr Martens sales growth slows but 'significant' profit increase still expected
Dr Martens PLC (LSE:DOCS) reported a decline in sales in the past quarter but said it is still on track to deliver "significant profit growth" in the current financial year. Revenues fell 3.1% to £253 million in the bootmaker's third quarter, worse than the 0.8% seen in the first half of the fiscal year.
🧮 Earnings Move Analyzer
Insider Trading
No insider trades found for DOCMF.
Senate Trading
No Senate trades found for DOCMF.
U.S. House Trading
No House trades found for DOCMF.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.